Panbela Therapeutics, Inc. (PBLA)
OTCMKTS
· Delayed Price · Currency is USD
0.372
-0.045 (-10.79%)
Jan 29, 2025, 4:00 PM EST
Panbela Therapeutics Employees
As of December 31, 2023, Panbela Therapeutics had 8 total employees, including 7 full-time and 1 part-time employees. The number of employees increased by 1 or 14.29% compared to the previous year.
Employees
8
Change (1Y)
1
Growth (1Y)
14.29%
Revenue / Employee
n/a
Profits / Employee
-$4,631,625
Market Cap
1.65M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
Silence Therapeutics | 109 |
SANUWAVE Health | 31 |
Panbela Therapeutics News
- 2 months ago - Panbela Therapeutics, Inc. (PBLA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Panbela Provides Business Update and Reports Q3 2024 Financial Results - GlobeNewsWire
- 6 months ago - Panbela Therapeutics, Inc. (PBLA) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 6 months ago - Panbela Therapeutics GAAP EPS of -$1.47 beats by $0.60 - Seeking Alpha
- 6 months ago - Panbela Provides Business Update and Reports Q2 2024 Financial Results - GlobeNewsWire
- 6 months ago - Panbela to Host Second Quarter 2024 Earnings Conference Call on Aug 13, 2024 - GlobeNewsWire
- 7 months ago - Panbela Therapeutics Announces Third Independent Safety Review of Phase 3 ASPIRE Clinical Trial DSMB Recommended Continuation with No Trial Modification - GlobeNewsWire
- 9 months ago - Panbela Therapeutics, Inc. (PBLA) Q1 2024 Earnings Call Transcript - Seeking Alpha